Q97828472

Summary

Q97828472 is an individual motion^[1].

Key Facts

• Q97828472 authored Cecilia Magnusson^[2].
• Q97828472's instance of is recorded as individual motion^[3].
• Q97828472's part of the series is recorded as motions of the 2009-2010 legislative session of the Riksdag^[4].
• Q97828472's language of work or name is recorded as Swedish^[5].
• Q97828472's publication date is recorded as +2009-10-05T00:00:00Z^[6].
• Q97828472's main subject is recorded as medication^[7].
• Q97828472's work available at URL is recorded as http://data.riksdagen.se/dokument/GX02So459^[8].
• Q97828472's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/GX02So459^[9].
• Q97828472's applies to jurisdiction is recorded as Sweden^[10].
• Q97828472's legal citation of this text is recorded as Mot. 2009/10:So459^[11].
• Q97828472's title is recorded as Klinisk läkemedelsprövning^[12].
• Q97828472's cites work is recorded as Q98462151^[13].
• Q97828472's maintained by WikiProject is recorded as Project Riksdagen's documents^[14].
• Q97828472's copyright status is recorded as public domain^[15].
• Q97828472's legislative committee is recorded as Committee on Health and Welfare^[16].
• Q97828472's Swedish Riksdag document ID is recorded as GX02So459^[17].

Body

Works and Contributions

Q97828472 authored Cecilia Magnusson^[2].